Construction of nanoscale multicompartment liposomes for combinatory drug delivery.

Liposomes are clinically used delivery systems for chemotherapeutic agents, biological macromolecules and diagnostics. Due to their flexibility in size and composition, different types of liposomes have been developed varying in surface and structural characteristics. Multicompartment liposomes constitute an attractive drug carrier system offering advantages in terms of inner vesicle protection, sustained drug release and possibility for combinatory (cocktail) therapies using a single delivery system. However, all previously described methodologies for multicompartment or multivesicular liposomes resulted in micrometer-sized vesicles limiting most pharmaceutical applications. In this work we report formulation of nanoscale multicompartment liposomes which maybe applicable for systemic administration. A small unilamellar vesicle (SUV) aqueous dispersion (DOPC:DOPG:CHOL) was used to hydrate a dried film of different lipid contents (DMPC:CHOL), followed by extrusion. The system was characterised by techniques such as photon correlation spectroscopy (PCS), zeta potential measurement, transmission electron microscopy (TEM) and laser scanning confocal microscopy (LSCM). We observed a single, multicompartment vesicle population composed of the two different bilayer types of approximately 200 nm in mean diameter rather than a mixture of two independent vesicle populations. In the case of tumour therapy, such multicompartment liposome systems can offer a single carrier for the delivery of two different modalities.

[1]  S. Sela,et al.  Preparation of multivesicular liposomes. , 1983, Biochimica et biophysica acta.

[2]  D. Lasič.  Liposomes within liposomes , 1997, nature.

[3]  Y. Kato,et al.  Potentiality of double liposomes containing salmon calcitonin as an oral dosage form. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Paramjit Singh,et al.  Development of novel fusogenic vesosomes for transcutaneous immunization. , 2006, Vaccine.

[5]  D. Papahadjopoulos,et al.  Medical applications of liposomes , 1998 .

[6]  Joseph A. Zasadzinski,et al.  Encapsulation of bilayer vesicles by self-assembly , 1997, nature.

[7]  V. Torchilin.  Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[8]  Y. Kato,et al.  In vitro characteristics of liposomes and double liposomes prepared using a novel glass beads method. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[9]  S. Mantripragada.  A lipid based depot (DepoFoam technology) for sustained release drug delivery. , 2002, Progress in lipid research.

[10]  T. Andresen,et al.  Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. , 2005, Progress in lipid research.

[11]  Joseph A. Zasadzinski,et al.  Nanocompartments Enclosing Vesicles, Colloids, and Macromolecules via Interdigitated Lipid Bilayers , 2002 .

[12]  Tsuneji Nagai,et al.  Sustained release of cisplatin from multivesicular liposomes: potentiation of antitumor efficacy against S180 murine carcinoma. , 2004, Journal of pharmaceutical sciences.

[13]  Yoshinori Kato,et al.  Preparation of novel double liposomes using the glass-filter method. , 2002, International journal of pharmaceutics.

[14]  M. Bally,et al.  The formulation of lipid-based nanotechnologies for the delivery of fixed dose anticancer drug combinations. , 2005, Current drug delivery.

[15]  D. Lasič.  Colloid chemistry. Liposomes within liposomes. , 1997, Nature.

[16]  Theresa M. Allen,et al.  Pharmacokinetics of long-circulating liposomes , 1995 .